Cancer News and Research

Latest Cancer News and Research

ZymoGenetics presents interim Interleukin 21 phase 2 results in renal cell cancer

ZymoGenetics, Inc. presented interim results today from a Phase 2 clinical trial evaluating Interleukin 21 (IL-21) in combination with Nexavar (sorafenib) tablets in patients with metastatic renal cell cancer.

22 Oct 2008

Gene study sheds new light on lung cancer

A multi-institution team, funded by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), today reported results of the largest effort to date to chart the genetic changes involved in the most common form of lung cancer, lung adenocarcinoma. The findings should help pave the way for more individualized approaches for detecting and treating the nation's leading cause of cancer deaths.

22 Oct 2008

Developing depression after a heart attack increases one’s risk of death or readmission

Science has found many links between depression and other serious medical illnesses, such as cancer, stroke, diabetes, and heart disease. For example, people who develop depression following a heart attack (myocardial infarction) or chest pain (angina) have an elevated risk of cardiac death or hospital readmission over the following year.

22 Oct 2008

Peregrine Pharmaceuticals reports on phase II trial of Bavituximab plus Docetaxel in advanced breast cancer

Peregrine Pharmaceuticals, Inc. has announced that updated preliminary data from the first stage of its Phase II trial evaluating bavituximab in combination with docetaxel showed that 10 of 14 (71%) evaluable breast cancer patients achieved an objective tumor response according to RECIST criteria.

22 Oct 2008

Sunshine could help fix male infertility

Australian fertility experts say a dose of daily sunshine could help men with fertility problems and they suggest couples struggling to conceive should consider getting out in the sunshine more often.

22 Oct 2008

Researchers identify novel type of antibody that potently inhibits HIV infection

A small antibody fragment that is highly effective in neutralizing the human immunodeficiency virus (HIV) by preventing the virus from entering cells has been identified by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

21 Oct 2008

A little exercise prolongs life expectancy for people with heart disease

Exercising once a week can help prolong life expectancy for people with heart disease according to a new study from the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway.

21 Oct 2008

Cell phones and brain cancer - major research initiatives needed

Major research initiatives are needed immediately to assess the possibility that using cellular phones may lead to an increased risk of brain tumors, according to an editorial in the November issue of the journal Surgical Neurology, published by Elsevier.

21 Oct 2008

Google.org helps identify future disease hot spots

Google.org, the philanthropic arm of Google, has announced grants of more than $14 million to support partners working in Southeast Asia and Africa to prevent the next pandemic.

21 Oct 2008

New imaging technique detects early cervical cancer

The Institute of Cancer Research and The Royal Marsden Hospital have developed a new imaging technique which locates previously undetectable early stage cervical cancers, according to research published in Radiology today (October 21).

21 Oct 2008

Laser treatment works well on sun-damaged skin

Researchers in the United States have found that sun-damaged skin responds well to laser treatment - which is good news for people with skin badly damaged by exposure to the sun.

21 Oct 2008

Gene could 'knock the sox' off cancer!

Australian scientists from the Institute for Molecular Bioscience at The University of Queensland (UQ), have identified a gene which could very well 'knock the sox' off cancer and lymphatic disorders.

21 Oct 2008

FDA grants orphan drug status to new 'Trojan Horse' like Ewing's Sarcoma drug

The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced today that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation's unique drug product for children with Ewing's Sarcoma cancer. The efforts to develop this drug were made possible by the generous volunteers and researchers in private industry and at two universities.

20 Oct 2008

Sun-damaged skin responds well to laser treatment

Researchers at the University of Michigan Health System Department of Dermatology have found scientific evidence that the appearance of sun-damaged skin may be improved by treatment with a topical product that increases the skin's sensitivity to light, followed by laser therapy.

20 Oct 2008

Johns Hopkins researchers detect sweet cacophany while listening to cellular cross-talk

Johns Hopkins scientists were dubious in the early 1980s when they stumbled on small sugar molecules lurking in the centers of cells; not only were they not supposed to be there, but they certainly weren't supposed to be repeatedly attaching to and detaching from proteins, effectively switching them on and off.

20 Oct 2008

Birth control has long term effect on hormone exposure

Researchers at Wake Forest University School of Medicine may be one step closer to understanding why past oral contraceptive use dramatically lowers the risk of ovarian and uterine cancers later in life.

20 Oct 2008

Bristol scientist puts the brakes on breast cancer

Why do breast cells grow out of control? The answer could be a step closer thanks to a grant of around £200,000 from one of the UK's leading breast cancer research charities, Breast Cancer Campaign, to University of Bristol scientist, Dr Claire Perks.

20 Oct 2008

Genentech announces phase III study of Avastin plus chemotherapy in adjuvant colon cancer will continue

Genentech, Inc. today announced that it has been informed by the National Surgical Adjuvant Breast and Bowel Project (NSABP) that an ongoing Phase III study (NSABP C-08) of Avastin (bevacizumab) plus chemotherapy in patients with early-stage colon cancer will continue as planned.

20 Oct 2008

New hope for a better treatment for childhood cancer

Children who are diagnosed with cancer could benefit from better diagnosis and treatment in the future thanks to a new research project involving clinicians and scientists at The University of Nottingham.

20 Oct 2008

New atlas maps geographical pattern of mortality in Great Britain

Researchers from the Universities of Bristol and Sheffield have created an 'atlas of death' which charts the geographical pattern of mortality in Great Britain. The full-colour atlas shows the wide variation in death rates from a variety of different causes, from heart attacks and cancer to suicide and murder, for over 1,000 neighbourhoods.

20 Oct 2008